MARKET OVERVIEW
An automatic injector is a syringe with a pre-charged dose of medicines and a spring-charged needle. When inserted into the body with a sliding motion, the device activates and administers a measured dosage of a medicament. Autoinjectors are routinely used for self-administration of epinephrine (to avoid anaphylaxis), migraine patients (for rapid pain relief), and medical and emergency treatments. Auto-injectors have a number of advantages, including reducing needle-related phobia condition, reducing the risk of needle-stick incidents, maintaining dose quality consistency, and helping with increased effectiveness.
MARKET SCOPE
The Global Automatic Injectors Professional Market Analysis to 2031 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the automatic injectors professional market with detailed market segmentation by therapy, type, route of administration and end user. The report provides key statistics on the market status of the leading automatic injectors professional market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on therapy the market is segmented as, RA, multiple sclerosis, diabetes, anaphylaxis, other therapies.
- Based on type the market is segmenetd as, disposable autoinjectors, resusable autoinjectors.
- Based on route of administration the market is segmenetd as, subcutaneous and IM.
- Based on end user the market is segmenetd as, home care setting, hospitals and clinics, ambulatory care settings.
MARKET DYNAMICS
Drivers:
- Growing cases of anaphylaxis disorders and other chronic diseases.
- Rising trend for self administration of medicaments due to growth in demand for homecare settings.
- Consistent R&D efforts for developing simple, cost-effective, and innovative technology-based autoinjectors for the treatment of chronic diseases such rheumatoid arthritis and multiple sclerosis are likely to fuel market growth throughout the forecast period.
- Increasing number of new product approvals and new product launches are also expected to spur market growth.
Restraints:
- However, availability of alternative treatment options is expected to restrain market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The automatic injectors professional market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the automatic injectors professional market in these regions.
IMPACT OF COVID-19 ON AUTOMATIC INJECTORS PROFESSIONAL MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the automatic injectors professional market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from automatic injectors professional market are anticipated to lucrative growth opportunities in the future with the rising demand for Automatic injectors professional in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the automatic injectors professional market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Eisai Co., Ltd
- Viatris Inc
- Ypsomed
- Amgen, Inc
- BD
- Teva Pharmaceuticals USA, Inc
- Antares Pharma
- Merck KGaA
- Owen Mumford
- Biogen
Automatic Injectors Professional Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2023 - 2031) | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Therapy
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Aerosol Paints Market
- Aesthetic Medical Devices Market
- Excimer & Femtosecond Ophthalmic Lasers Market
- Mobile Phone Insurance Market
- Virtual Production Market
- Vision Care Market
- Influenza Vaccines Market
- Ceramic Injection Molding Market
- Cosmetic Bioactive Ingredients Market
- Single Pair Ethernet Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. Eisai Co., Ltd
2. Viatris Inc
3. Ypsomed
4. Amgen, Inc
5. BD
6. Teva Pharmaceuticals USA, Inc
7. Antares Pharma
8. Merck KGaA
9. Owen Mumford
10. Biogen
1. Eisai Co., Ltd
2. Viatris Inc
3. Ypsomed
4. Amgen, Inc
5. BD
6. Teva Pharmaceuticals USA, Inc
7. Antares Pharma
8. Merck KGaA
9. Owen Mumford
10. Biogen